Home › Funds › NATIXIS ADVISORS, LLC › AZN

NATIXIS ADVISORS, LLC position in AZN

ASTRAZENECA PLC · Health Care

NATIXIS ADVISORS, LLC reported holding 1,978,508 shares of AZN (ASTRAZENECA PLC) in its Q2 2026 13F filing — a position valued at US$375.2M, representing 0.42% of its reported portfolio and ranking #43 among its reported holdings. NATIXIS ADVISORS, LLC has disclosed AZN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.98M sh
Reported value held$375.16M
Portfolio Weight0.42%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How NATIXIS ADVISORS, LLC's AZN position evolved

NATIXIS ADVISORS, LLC first disclosed a stake in AZN in Q3 2023 at 1,172,332 shares (US$79.4M). The position peaked in Q2 2026 at 1,978,508 shares, worth US$375.2M. Across 12 filings, NATIXIS ADVISORS, LLC increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,978,508 shares valued at US$375.2M — an increase of 666,009 shares quarter over quarter.. Notable position changes include a 25% increase in Q1 2024 (shares rose 15% over the following quarter), a 36% trim in Q1 2026 (shares fell 4% over the following quarter), a 51% increase in Q2 2026 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.17M $79.39M New
Q4 2023 1.25M $84.23M Add
Q1 2024 1.57M $106.08M Add
Q2 2024 1.84M $143.79M Add
Q3 2024 1.96M $152.77M Add
Q4 2024 2.06M $134.98M Add
Q1 2025 2.24M $164.35M Add
Q2 2025 1.84M $128.43M Reduce
Q3 2025 2.10M $161.14M Add
Q4 2025 2.05M $188.78M Reduce
Q1 2026 1.31M $258.85M Reduce
Q2 2026 1.98M $375.16M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AZN and 13F data

AZN (ASTRAZENECA PLC) is a Health Care company. 71 other funds we track also report a position in AZN — the largest reported positions include Evelyn Partners Group Ltd (US$41.52B), Banque Cantonale Vaudoise (US$11.31B), INVESTOR AB (US$9.78B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AZN

All AZN fund holders →

FAQ

How long has NATIXIS ADVISORS, LLC held AZN?

NATIXIS ADVISORS, LLC has disclosed AZN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is NATIXIS ADVISORS, LLC's current position in AZN?

As of Q2 2026, NATIXIS ADVISORS, LLC holds 1.98M shares of AZN (ASTRAZENECA PLC), valued at $375.16M, representing 0.42% of its reported portfolio and ranking #43.

Has NATIXIS ADVISORS, LLC been buying or selling AZN?

In the latest 13F filing (Q2 2026), NATIXIS ADVISORS, LLC increased its position in AZN. The position peaked in Q2 2026 at 1.98M shares.

Which other funds hold AZN?

Other major institutional holders of AZN include Evelyn Partners Group Ltd, Banque Cantonale Vaudoise, INVESTOR AB, among 71 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.